Effect of Bivalirudin on Aortic Valve Intervention Outcomes.
- Conditions
- - patients undergoing TAVR via transfemoral access - aortic valve replacement- aortaklepvervanging
- Registration Number
- NL-OMON27624
- Lead Sponsor
- The Medicines Company8 Sylvan WayParsippany, NJ07054
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 620
Inclusion Criteria
1. ≥ 18 years of age;
2. High risk (Euroscore ≥18, or considered inoperable) for surgical aortic valve replacement;
Exclusion Criteria
1. Contraindication to bivalirudin or UFH;
2. Refusal to receive blood transfusion;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method